Cannabis company The Green Organic Dutchman Holdings Ltd TGOD's shares have lost more than half their value in the last month.
The sell-off might present a good buying opportunity, as the stock has upside ahead, according to Canaccord Genuity.
The Analyst
Canaccord's Derek Dley initiated coverage of The Green Organic Dutchman Holdings Ltd's Canadian-listed stock with a Speculative Buy rating and a U.S. dollar equivalent price target of $5.40, implying upside of more than 88 percent.
The Thesis
The Green Organic Dutchman is well-positioned to take advantage of multiple international opportunities, but also has a strong exposure to the organic Canadian marijuana market, Dley said in the initiation note.
The company is well-funded to reach an annual capacity of around 430,000 pounds, which excludes hemp, the analyst said. TGOD is estimated to have around $355 million in cash, including in-the-money warrants, he said.
Full production capacity should result in annual revenue between $1.1 billion and $1.4 billion, according to Canaccord.
Dley expects TGOD to become free cash flow positive in 2020. The company also has a strong competitive advantage with its organic cannabis products offering, he said.
TGOD has already made some progress internationally with the acquisition of HemPoland, which offers exposure to 14 European countries, the analyst said.
Canaccord's price target implies a forward 2020 EBITDA multiple of 13.4x, which is lower than the average mid-tier Canadian LPs multiple of 15.9x. The discount to the EBITDA multiple is due to the early stage of the company's operations, the sell-side firm said.
The Price Action
The Green Organic Dutchman's over-the-counter stock was up 2.8 percent at $2.93 at the time of publication Thursday.
Related Links:
Social Justice Or Commercialization? Expert Views On Michigan's Recreational Marijuana Proposal
Cannabis Company Verano Holdings Launches With $120 Million Investment
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!